Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3215 of 6351
-
Lung cancer combo trial halted early – what we know
Disease control Stopped earlySLC-391 is a novel, potent and specific small molecule inhibitor of receptor tyrosine kinase AXL with desirable potency and pharmaceutical properties. The study is being done to evaluate the safety and pharmacokinetic (PK) profile of SLC-391 in combination with pembrolizumab in …
Phase 1/2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New online program eases Kids' cancer return to school
Symptom relief CompletedThe aim of this action research is to: Stage 1: Conduct an in-depth investigation into the adaptation challenges faced by children aged 8-17 who are being treated for cancer during their return to school, from both the children's and parents' perspectives; Stage 2: Develop a st…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Parkinson's patients try Brain-Boosting workouts from home
Symptom relief CompletedThe ability to respond to multiple stimuli is impaired in Parkinson's patients. Traditional rehabilitation approaches focus only on balance and gait training, but individuals with Parkinson's disease need to perform multiple tasks in daily life.
Sponsor: Yeditepe University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a smartphone app ease the burden of Alzheimer's caregiving?
Symptom relief Recruiting nowThis study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by car…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New Light-Based monitor could spot brain trouble in newborns seconds after birth
Knowledge-focused Recruiting nowThe transition from fetus to newborn is a complex physiological process. Monitoring this process to detect potential disruptions is critical but remains a challenge. Initial evaluation of neonates is usually based on visual inspection, palpation and/or auscultation, and response …
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
VR workouts boost fitness in cystic fibrosis kids
Symptom relief CompletedThe goal of this clinical trial is to investigate the effects of a-12-week virtual reality exercise program, applied as tele-exercise, on the exercise capacity of children with cystic fibrosis, whose physical activity level is further restricted during the pandemic. The main ques…
Sponsor: Koç University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New drug duo takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study will evaluate the safety and efficacy of DS-1103a combination therapy in participants with advanced solid tumors.
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Personalized cell therapy shows promise for Hard-to-Treat cancers
Disease control Stopped earlyBackground: Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by harvesting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro and then infusing back to patients. TIL therapy has shown strong efficacy for the treatment o…
Phase 1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental combo for head and neck cancer shows promise, but trial halted early
Disease control Stopped earlyOpen-label, Phase II, randomized, controlled study evaluating the efficacy and safety of danvatirsen in combination with pembrolizumab compared with pembrolizumab alone as first-line treatment of patients with recurrent/metastatic (R/M) HNSCC. Two-thirds of patients will be rando…
Phase 2 • Sponsor: Flamingo Therapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can daily sensory activities boost preterm baby brain development?
Knowledge-focused Recruiting nowThe long-term goal of this project is to improve the health and well-being of preterm infants and their parents. Although there is evidence to support positive multisensory interventions in the NICU, these interventions are often applied in an inconsistent manner, reducing their …
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Muscle-Building supplement tested in female athletes after ACL surgery
Disease control Recruiting nowThe proposed project will evaluate the musculoskeletal outcomes of quadriceps and hamstring muscle size and function following orthopedic knee surgery involving anterior cruciate ligament (ACL) repair or reconstruction. Currently, the research team collaborates with a team of ort…
Phase 2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a cooling blanket beat heat stroke faster?
Symptom relief Recruiting nowThe goal of this clinical trial is to test the cooling effect of cooling blanket in patients with heat stroke. The main questions it aims to answer are: * the cooling rate of cooling blanket in patients with heat stroke * the relationship between cooling blanket and outcomes in …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Could a cancer drug tame rare clotting disorder?
Disease control Recruiting nowThe purpose of this study is to see if the study medication, daratumumab, is safe to treat individuals with Anti-Phospholipid Syndrome (APS). Three daratumumab dosing cohorts are planned with up to six participants in each dosing cohort with the potential to enroll an additional…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can an app help people who stutter speak more fluently?
Symptom relief OngoingThe purpose of the study is to use altered auditory vocal feedback to increase fluency in people who stutter and to examine changes in this effect over the course of a one month period occurring outside the laboratory setting.
Sponsor: Massachusetts Institute of Technology • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Brain scans may predict social anxiety treatment success
Knowledge-focused Recruiting nowThe purpose of this clinical trial is to answer the question: can the investigators predict which adults with social anxiety disorder (SAD) will successfully respond to treatment? To answer this question, the investigators plan to recruit 190 adult participants who experience ext…
Sponsor: Boston University Charles River Campus • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New handheld device aims to soothe stubborn muscle pain
Symptom relief Recruiting nowSonodyn is an investigational device that within this clinical investigation is intended for use in patients suffering from low back pain, tension headache or neck pain, originating from therapy-resistant myofascial pain syndrome. Myofascial pain syndrome is a prevalent pain con…
Sponsor: Sobet AG • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New implant aims to tame glaucoma with one dose
Disease control CompletedThis clinical study has two phases: Phase 1 and Phase 2a. Phase 1 is an open-label, single ascending dose (SAD), while Phase 2a is a randomized, single-masked (participant) with a sham control.
Phase 1/2 • Sponsor: Perfuse Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Smart bassinets and mentors: a new rx for doctor mom burnout?
Symptom relief CompletedThe goal of this clinical trial is to determine the impact of a parental support package for new trainee mothers which focuses on mentorship, lactation, and sleep, and access to perinatal care. The main questions it aims to answer are whether this set of interventions will improv…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can music retrain the brain after psychosis? new study tests Computer-Assisted therapy
Disease control Recruiting nowThe use of music in the field of cognitive remediation is growing and much research has focused on the relevance and effectiveness of its use in care. Studies have therefore made it possible to show the relevance of the use of musical material in the remediation of patients with …
Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Sound therapy may tame sensory overload in fragile x kids
Knowledge-focused Recruiting nowFragile X Syndrome (FXS) is a complex neurodevelopmental disorder caused by a mutation on the X chromosome. Scientists have investigated FXS extensively in both humans and animals. Thus far, phenotypic rescue in animal models has not resulted in treatment breakthroughs in humans,…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC